• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物治疗、介入治疗和手术治疗对慢性心力衰竭患者比例性和非比例性功能性二尖瓣反流的对比影响。

Contrasting Effects of Pharmacological, Procedural, and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.

机构信息

Division of Cardiology, Department of Internal Medicine and the Baylor Scott and White Heart and Vascular Hospital, Baylor University Medical Center, Dallas, TX (M.P., P.A.G.).

Imperial College, London, United Kingdom (M.P.).

出版信息

Circulation. 2019 Aug 27;140(9):779-789. doi: 10.1161/CIRCULATIONAHA.119.039612. Epub 2019 May 1.

DOI:10.1161/CIRCULATIONAHA.119.039612
PMID:31070944
Abstract

Two distinct pathways can lead to functional mitral regurgitation (MR) in patients with chronic heart failure and a reduced ejection fraction. When remodeling and enlargement of the left ventricle (LV) cause annular dilatation and tethering of the mitral valve leaflets, there is a linear relationship between LV end-diastolic volume and the effective regurgitant orifice area of the mitral valve. These patients, designated as having proportionate MR, respond favorably to treatments that lead to reversal of LV remodeling and a decrease in LV volumes (eg, neurohormonal antagonists and LV assist devices), but they may not benefit from interventions that are directed only at the mitral valve leaflets (eg, transcatheter mitral valve repair). In contrast, when ventricular dyssynchrony causes functional MR attributable to unequal contraction of the papillary muscles, the magnitude of regurgitation is greater than that predicted by LV volumes. These patients, designated as having severe but disproportionate MR, respond favorably to treatments that are directed to the mitral valve leaflets or their supporting structures (eg, cardiac resynchronization or transcatheter mitral valve repair), but they may derive little benefit from interventions that act only to reduce LV cavity size (eg, pharmacological treatments). This novel conceptual framework reflects the important interplay between LV geometry and mitral valve function in determining the clinical presentation of patients, and it allows characterization of the determinants of functional MR to guide the most appropriate therapy in the clinical setting.

摘要

两种不同的途径可导致射血分数降低的慢性心力衰竭患者发生功能性二尖瓣反流(MR)。当左心室(LV)重构和扩大导致瓣环扩张和二尖瓣瓣叶牵拉时,LV 舒张末期容积与二尖瓣有效反流口面积之间存在线性关系。这些患者被指定为具有比例性 MR,对导致 LV 重构逆转和 LV 容积减少的治疗反应良好(例如神经激素拮抗剂和 LV 辅助装置),但他们可能不会从仅针对二尖瓣瓣叶的干预措施中获益(例如,经导管二尖瓣修复)。相比之下,当心室不同步导致由于乳头肌收缩不均引起的功能性 MR 时,反流程度大于 LV 容积预测的程度。这些患者被指定为具有严重但不成比例的 MR,对针对二尖瓣瓣叶或其支持结构的治疗(例如心脏再同步或经导管二尖瓣修复)反应良好,但他们可能从仅作用于减小 LV 腔大小的干预措施中获益甚微(例如药物治疗)。这个新的概念框架反映了 LV 几何形状和二尖瓣功能之间的重要相互作用,在确定患者的临床表现方面具有重要意义,并允许对功能性 MR 的决定因素进行特征描述,以指导临床环境中的最适当治疗。

相似文献

1
Contrasting Effects of Pharmacological, Procedural, and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.药物治疗、介入治疗和手术治疗对慢性心力衰竭患者比例性和非比例性功能性二尖瓣反流的对比影响。
Circulation. 2019 Aug 27;140(9):779-789. doi: 10.1161/CIRCULATIONAHA.119.039612. Epub 2019 May 1.
2
Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials.比例性和非比例性功能性二尖瓣反流:一个新的概念框架,调和了 MITRA-FR 和 COAPT 试验的结果。
JACC Cardiovasc Imaging. 2019 Feb;12(2):353-362. doi: 10.1016/j.jcmg.2018.11.006. Epub 2018 Dec 12.
3
New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation.支持区分成比例和不成比例功能性二尖瓣反流的新概念框架的新证据。
JAMA Cardiol. 2020 Apr 1;5(4):469-475. doi: 10.1001/jamacardio.2019.5971.
4
Mechanism of decrease in mitral regurgitation after cardiac resynchronization therapy: optimization of the force-balance relationship.心脏再同步治疗后二尖瓣反流减少的机制:力平衡关系的优化
Circ Cardiovasc Imaging. 2009 Nov;2(6):444-50. doi: 10.1161/CIRCIMAGING.108.823732. Epub 2009 Sep 22.
5
Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.采用永久性经皮经腔二尖瓣环成形术系统治疗功能性二尖瓣反流:多中心国际经皮经腔二尖瓣环成形术系统减少心力衰竭患者二尖瓣反流试验的结果。
Am Heart J. 2013 May;165(5):761-9. doi: 10.1016/j.ahj.2013.01.010. Epub 2013 Feb 14.
6
Neurohormonal and Transcatheter Repair Strategies for Proportionate and Disproportionate Functional Mitral Regurgitation in Heart Failure.心力衰竭中比例性和非比例性功能二尖瓣反流的神经激素及经导管修复策略
JACC Heart Fail. 2019 Jun;7(6):518-521. doi: 10.1016/j.jchf.2019.03.016. Epub 2019 May 8.
7
Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation.心脏再同步治疗对继发性二尖瓣反流患者二尖瓣装置几何形态及临床结局的影响
Echocardiography. 2017 Nov;34(11):1561-1567. doi: 10.1111/echo.13690. Epub 2017 Sep 12.
8
Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After MitraClip Implantation: Results From the Mitra-FR Trial.经二尖瓣夹合术治疗后二尖瓣反流严重程度和左心室重构对预后的影响:Mitra-FR 试验结果。
JACC Cardiovasc Imaging. 2021 Apr;14(4):742-752. doi: 10.1016/j.jcmg.2020.07.021. Epub 2020 Sep 16.
9
Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry.下壁心肌梗死后心脏再同步治疗对继发性二尖瓣反流及二尖瓣几何形态的影响
Pacing Clin Electrophysiol. 2018 Feb;41(2):114-121. doi: 10.1111/pace.13255. Epub 2018 Jan 16.
10
Left Ventricular End-Systolic Dimension and Outcome in Patients With Heart Failure Undergoing Percutaneous MitraClip Valve Repair for Secondary Mitral Regurgitation.经皮二尖瓣夹修复术治疗继发性二尖瓣反流的心力衰竭患者的左心室收缩末期内径与结局。
Am J Cardiol. 2020 Jul 1;126:56-65. doi: 10.1016/j.amjcard.2020.03.045. Epub 2020 Apr 7.

引用本文的文献

1
Diagnosis and Diagnostic Challenges of Secondary Mitral Regurgitation in the Era of Transcatheter Edge-to-Edge Repair of the Mitral Valve.二尖瓣经导管缘对缘修复时代继发性二尖瓣反流的诊断及诊断挑战
J Clin Med. 2025 Jun 26;14(13):4518. doi: 10.3390/jcm14134518.
2
Disproportionate vs. Proportionate Secondary Mitral Regurgitation: A Long-Term Pilot Analysis After Mitral Valve Surgery.不成比例与成比例的继发性二尖瓣反流:二尖瓣手术后的长期初步分析
J Clin Med. 2025 May 15;14(10):3470. doi: 10.3390/jcm14103470.
3
Machine-learning phenotyping of patients with functional mitral regurgitation undergoing transcatheter edge-to-edge repair: the MITRA-AI study.
经导管缘对缘修复治疗功能性二尖瓣反流患者的机器学习表型分析:MITRA-AI研究
Eur Heart J Digit Health. 2025 Feb 13;6(3):340-349. doi: 10.1093/ehjdh/ztaf006. eCollection 2025 May.
4
Urgent Transcatheter Mitral Edge-to-Edge Repair Is Associated With Worse in-Hospital Outcomes: A Nationwide Analysis.紧急经导管二尖瓣缘对缘修复与更差的院内结局相关:一项全国性分析。
Clin Cardiol. 2025 Mar;48(3):e70067. doi: 10.1002/clc.70067.
5
Association between the proportionality of functional mitral regurgitation and survival after mitral valve operation.功能性二尖瓣反流比例与二尖瓣手术后生存率之间的关联。
JTCVS Open. 2024 Jun 22;22:176-188. doi: 10.1016/j.xjon.2024.06.006. eCollection 2024 Dec.
6
Outcomes of COMBO therapy for severe mitral regurgitation compared with transcatheter edge-to-edge repair.与经导管缘对缘修复术相比,重度二尖瓣反流的联合治疗效果。
Front Cardiovasc Med. 2024 Feb 26;11:1223588. doi: 10.3389/fcvm.2024.1223588. eCollection 2024.
7
Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.房颤消融与药物治疗疗效的区域差异:CABANA试验结果
Am Heart J. 2024 Apr;270:103-116. doi: 10.1016/j.ahj.2024.01.009. Epub 2024 Feb 1.
8
Contemporary Echocardiographic Evaluation of Mitral Regurgitation and Guidance for Percutaneous Mitral Valve Repair.二尖瓣反流的当代超声心动图评估及经皮二尖瓣修复术的指导
J Clin Med. 2023 Nov 15;12(22):7121. doi: 10.3390/jcm12227121.
9
Patient-Specific Quantitative In-Vivo Assessment of Human Mitral Valve Leaflet Strain Before and After MitraClip Repair.患者特异性定量活体评估二尖瓣前叶应变在 MitraClip 修复前后的变化。
Cardiovasc Eng Technol. 2023 Oct;14(5):677-693. doi: 10.1007/s13239-023-00680-4. Epub 2023 Sep 5.
10
Quantitative in vivo assessment of human mitral valve coaptation area after undersized ring annuloplasty repair for ischemic mitral regurgitation.缺血性二尖瓣反流的小号环成形修复术后人体二尖瓣瓣叶贴合面积的体内定量评估。
JTCVS Tech. 2022 Oct 1;16:49-59. doi: 10.1016/j.xjtc.2022.09.013. eCollection 2022 Dec.